RJA
CMPS

Raymond James & Associates’s Compass Pathways CMPS Stock Holding History

Raymond James & Associates’s Portfolio CMPS Stock Details CMPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,595
Closed -$76.1K – 4014
2024
Q2 		$76.1K Sell
12,595
-19,405
-61% -$153K ﹤0.01% 3757
2024
Q1 		$266K Buy
32,000
+4,079
+15% +$41.1K ﹤0.01% 3443
2023
Q4 		$244K Buy
27,921
+190
+0.7% +$1.23K ﹤0.01% 3407
2023
Q3 		$205K Buy
+27,731
New +$246K ﹤0.01% 3437
2023
Q2 		– Sell
-11,128
Closed -$111K – 3857
2023
Q1 		$111K Sell
11,128
-5,963
-35% -$54.9K ﹤0.01% 3628
2022
Q4 		$137K Sell
17,091
-13,622
-44% -$137K ﹤0.01% 3562
2022
Q3 		$330K Sell
30,713
-2,700
-8% -$40.5K ﹤0.01% 3118
2022
Q2 		$362K Sell
33,413
-1,022
-3% -$10.3K ﹤0.01% 3112
2022
Q1 		$444K Buy
34,435
+1,341
+4% +$20K ﹤0.01% 3139
2021
Q4 		$731K Buy
+33,094
New +$1.05M ﹤0.01% 2825
2021
Q3 		– Sell
-17,679
Closed -$674K – 4140
2021
Q2 		$674K Buy
+17,679
New +$632K ﹤0.01% 2865

Other funds holding CMPS

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Raymond James & Associates's CMPS Position: Q3 2024 in Review

Raymond James & Associates sold out of Compass Pathways (CMPS) in Q3 2024, closing a stake of 12,595 shares — an estimated $76.1K sold.

Raymond James & Associates first reported a position in CMPS in Q2 2021 and held it in 11 quarters. The position peaked at $731K in Q4 2021. 130 funds tracked by Wall St. Rank hold CMPS as of Q3 2024.

  • Raymond James & Associates reported no remaining Compass Pathways position as of Q3 2024 after selling out during the quarter.
  • Raymond James & Associates sold 12,595 Compass Pathways shares in Q3 2024, an estimated $76.1K.
  • Raymond James & Associates first reported a position in Compass Pathways in Q2 2021 and held it in 11 quarters.
  • Raymond James & Associates's Compass Pathways position peaked at $731K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held Compass Pathways as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.